
    
      A prospective cohort study of patients who undergo endovenous sclerotherapy over 2 years.
      There are no deviations in usual clinical assessment and care of patients seeking varicose
      vein treatment. The purpose of this protocol is only to collect clinical and biomarker
      information related to this standard treatment.
    
  